Protagen AG Sells Service Business
News Jul 02, 2013
The company was spun out in January 2012 and continued the business of the former operational division Protein Services, which accumulated unique expertise in the GMP-compliant protein analytics over the years.
“The sale of this profitable service business to a potent investor with complementary portfolio companies secures a sustainable growth for PPS, an internationally renowned specialist for protein characterization and biosimilar comparability. On the other hand, the capital injection generated by this transaction is a solid mid-term financing opportunity for the Protagen strategy in the area of novel diagnostics, i.e. Dx and CDx, and enables to start the development of own products for this growing market immediately. With this step, Protagen positions itself as highly attractive target for new VC investors”, states Dr. Stefan Müllner, CEO.
Aqueous Humor Could Help Direct Retinoblastoma TreatmentNews
Study demonstrates that aqueous humor removed during chemotherapy treatment contains tumor DNA, which could be used for a surrogate 'liquid' biopsy.READ MORE
QIAGEN and CENTOGENE to Collaborate in Bioinformatics for Genetic DiseasesNews
Aiding the analysis of hereditary disorders by integrating genomic and clinical databases.READ MORE